Literature DB >> 3063254

Guanine for DNA synthesis. A compulsory route through ribonucleotide reductase.

D S Duan1, W Sadee.   

Abstract

Two alternative pathways for the synthesis of dGTP and its incorporation into DNA were studied: guanine (Gua)----GMP----GDP----dGDP----dGTP----DNA and dG----dGMP----dGDP----dGTP----DNA. To determine the contribution of each pathway to DNA synthesis independently of each other, [14C]Gua and [3H]dG tracer experiments were performed in a double-mutant S-49 mouse T-lymphoma cell line, dGuo-L, with purine nucleoside phosphorylase (EC 2.4.2.1)-deficiency and dGTP-feedback-resistant ribonucleotide reductase (RR, EC 1.17.4.1). In this cell line, dGTP pools can be selectively elevated by exogenous dG without affect RR and DNA synthesis. Although [3H]dG, but not [14C]Gua (up to 200 microM), readily expanded the cellular dGTP pool in a dose-dependent fashion in asynchronous cells, only a small fraction of the Gua flux into DNA was derived from [3H]dG, with the major fraction coming from [14C]Gua. H.p.l.c. analysis of G1- and partially enriched S-phase cells revealed that [3H]dGTP only accumulates in G1- but not in S-phase cells because of a rapid turnover of the dGTP pool during DNA synthesis. These results fail to provide evidence for cellular dGTP compartmentation and suggest that the pathway dG----dGMP----dGDP----dGTP alone has insufficient capacity to maintain DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063254      PMCID: PMC1135346          DOI: 10.1042/bj2551045

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: genetic model for immunodeficiency disease.

Authors:  B Ullman; L J Gudas; S M Clift; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

2.  Cell-cycle analysis in 20 minutes.

Authors:  H A Crissman; R A Tobey
Journal:  Science       Date:  1974-06-21       Impact factor: 47.728

Review 3.  Biochemistry of diseases of immunodevelopment.

Authors:  D W Martin; E W Gelfand
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

Review 4.  Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.

Authors:  G Weber
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

5.  In vivo rates of pyrimidine nucleotide metabolism in intact mouse T-lymphoma (s-49) cells treated with 5-fluorouracil.

Authors:  J Maybaum; M B Cohen; W Sadee
Journal:  J Biol Chem       Date:  1981-03-10       Impact factor: 5.157

6.  Guanine nucleotide depletion and toxicity in mouse T lymphoma (S-49) cells.

Authors:  M B Cohen; J Maybaum; W Sadee
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

7.  High-pressure liquid chromatography--ultraviolet analysis of intracellular nucleotides.

Authors:  A L Pogolotti; D V Santi
Journal:  Anal Biochem       Date:  1982-11-01       Impact factor: 3.365

8.  Guanine ribonucleotide depletion in mammalian cells. A target of purine antimetabolites.

Authors:  B T Nguyen; M B Cohen; W Sadée
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Multienzyme complex for metabolic channeling in mammalian DNA replication.

Authors:  G Prem veer Reddy; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Distinct effects of adenine and guanine starvation on DNA synthesis associated with different pool sizes of nucleotide precursors.

Authors:  D S Duan; W Sadée
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

View more
  2 in total

1.  Mechanisms of 2'-deoxyguanosine toxicity in mouse T-lymphoma cells with purine nucleoside phosphorylase deficiency and resistance to inhibition of ribonucleotide reductase by dGTP.

Authors:  D S Duan; T Nagashima; T Hoshino; F Waldman; K Pawlak; W Sadee
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

2.  Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11.

Authors:  Xiao-Xin Sun; Mu-Shui Dai; Hua Lu
Journal:  J Biol Chem       Date:  2008-02-27       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.